Characteristics | ||||||
---|---|---|---|---|---|---|
 | Immuno-virologic success (VL <400 copies and CD4 change >=50 cells) | Virologic discordance (VL >400 copies and CD4 change >=50 cells) | Unadjusted | p-value | Adjusted | p-value |
 | (n = 338) | (n = 94) | OR (95% CI) |  | OR (95% CI) |  |
Gender | Â | Â | Â | Â | Â | Â |
Female | 214 (63%) | 58 (62%) | Ref | Â | Ref | Â |
Male | 124 (37%) | 36 (38%) | 1.07 (0.67-1.72) | 0.78 | 1.25 (0.72-2.01) | 0.54 |
Age at HAART Initiation (years) | ||||||
< 30 | 269 (80%) | 66 (70%) | 1.65 (0.99-2.77) | 0.06 | 1.58 (0.88-3.01) | 0.08 |
>30 | 69 (20%) | 28 (30%) | Ref | Â | Ref | Â |
Currently married | ||||||
Yes | 188 (56%) | 57 (61%) | 1.23 (0.77-1.96) | 0.39 | Â | Â |
No | 150 (44%) | 37 (39%) | Ref | Â | Â | Â |
HIV disclosure | ||||||
Yes | 317 (93.8%) | 89 (95%) | 1.18 (0.43-3.22) | 0.75 | Â | Â |
No | 21 (6.2%) | 5 (5%) | Ref | Â | Â | Â |
Tuberculosis History | ||||||
Yes | 49 (14.5%) | 17 (18.1%) | 1.30 (0.71-2.39) | 0.39 | 0.92 (0.47-1.86) | 0.92 |
No | 289 (85.5%) | 77 (81.9%) | Ref | Â | Ref | Â |
Baseline CD4 cell count (n = 613) | ||||||
< 50 | 57 (16.9%) | 19 (20.2%) | Ref | Â | Ref | Â |
50 and < 200 | 196 (58%) | 59 (62.8%) | 0.90 (0.50-1.64) | 0.74 | 0.90 (0.56-1.61) | 0.81 |
200 and <350 | 72 (21.3%) | 13 (13.8%) | 0.54 (0.25-1.19) | 0.13 | 0.59 (0.20-1.38) | 0.22 |
350 and < 500 | 9 (2.7%) | 3 (3.2%) | 1.00 (0.25-4.08) | 1.0 | 0.58 (0.16-3.22) | 0.65 |
>=500 | 4 (1.1%) | 0 (0%) | Omitted | Â | Â | Â |
Baseline anemia (Hemoglobin < 10 g/dl) (n = 546) | ||||||
Yes | 103 (30.5%) | 40 (42.5%) | 1.69 (1.05-2.70) | 0.03 | 1.80 (1.13-2.85) | 0.04 |
No | 235 (69.5%) | 54 (57.5%) | Ref | Â | Ref | Â |
Antiretroviral drug regimen at baseline | ||||||
ZDV / 3TC / NVP or EFV | 139 (41%) | 37 (39%) | Ref | Â | Ref | Â |
D4T / 3TC / NVP or EFV | 24 (7%) | 9 (10%) | 1.41 (0.60-3.29) | 0.43 | 1.21 (0.42-3.95) | 0.59 |
TDF / 3TC of FTC / NVP or EFV | 175 (52%) | 48 (51%) | 1.03 (0.64-1.67) | 0.90 | 0.89 (0.46-1.43) | 0.86 |
Drug adherence by pharmacy refill record | ||||||
>= 95% | 322 (95%) | 79 (84%) | Ref | Â | Ref | Â |
< 95% | 16 (5%) | 15 (16%) | 3.82 (1.81-8.06) | 0.001 | 3.90 (1.92-8.24) | 0.001 |
Employment status | ||||||
Employed | 288 (85.2%) | 75 (79.8%) | Ref | Â | Ref | Â |
Unemployed | 46 (13.6%) | 18 (19.1%) | 1.50 (0.82-2.74) | 0.18 | 1.44 (0.77-2.56) | 0.31 |
Retired | 1 (0.3%) | 0 (0%) | Omitted | Omitted | Omitted | Â |
Student | 3 (0.9%) | 1 (1.1%) | 1.28 (0.13-12.5) | 0.83 | 1.33 (0.15-11.7) | 0.87 |
Highest educational achievement | ||||||
No formal education | 152 (45%) | 58 (61.7%) | Ref | Â | Ref | Â |
Primary education | 84 (24.9%) | 18 (19.2%) | 0.56 (0.31-1.02) | 0.06 | 0.56 (0.29-1.01) | 0.06 |
Secondary education | 14 (4.1%) | 5 (5.3%) | 0.94 (0.32-2.72) | 0.90 | 0.92 (0.27-2.49) | 0.72 |
Post-secondary / Tertiary / Advanced education | 88 (26%) | 13 (13.8%) | 0.40 (0.21-0.77) | 0.006 | 0.40 (0.22-0.68) | 0.004 |
Socio-economic class | ||||||
Class 1 | 14 (4.1%) | 4 (4.3%) | Ref | Â | Â | Â |
Class 2 | 54 (16%) | 14 (14.9%) | 0.91 (0.26-3.19) | 0.88 | Â | Â |
Class 3 | 147 (43.5%) | 33 (35.1%) | 0.79 (0.24-2.54) | 0.69 | Â | Â |
Class 4 | 110 (32.5%) | 41 (43.6%) | 1.30 (0.41-.4.19) | 0.66 | Â | Â |
Class 5 | 13 (3.9%) | 2 (2.1%) | 0.54 (0.08-3.45) | 0.51 | Â | Â |
Current smoker | ||||||
Yes | 5 (1.5%) | 1 (98.9%) | 0.72 (0.08-6.21) | 0.76 | Â | Â |
No | 333 (98.5%) | 93 (1.1%) | Ref | Â | Â | Â |
Current alcohol user | ||||||
Yes | 28 (8.3%) | 8 (8.5%) | 1.03 (0.45-2.34) | 0.94 | Â | Â |
No | 310 (91.7%) | 86 (91.5%) | Ref | Â | Â | Â |
Current herbal drug user | ||||||
Yes | 7 (2.1%) | 3 (3.2%) | 1.56 (0.39-6.15) | 0.53 | Â | Â |
No | 331 (97.9%) | 91 (96.8%) | Ref | Â | Â | Â |